Drug
Fluconazole 150 mg
Fluconazole 150 mg is a pharmaceutical drug with 6 clinical trials. Currently 4 active trials ongoing.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
4(67%)
Phase Distribution
Ph phase_4
2
33%
Ph not_applicable
1
17%
Ph phase_2
1
17%
Ph early_phase_1
1
17%
Phase Distribution
1
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
4
trials recruiting
Total Trials
6
all time
Status Distribution
Active(4)
Other(2)
Detailed Status
Recruiting3
unknown2
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
4
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Early Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 42 (40.0%)
N/A1 (20.0%)
Trials by Status
unknown233%
recruiting350%
active_not_recruiting117%
Recent Activity
4 active trials
Showing 5 of 6
active_not_recruitingearly_phase_1
Vulvovaginal Candidiasis in Canadian Females
NCT04930107
recruitingnot_applicable
The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting
NCT07396857
recruitingphase_4
Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis
NCT07342153
recruitingphase_4
Endothelial Derived Hyperpolarization Factor and Vascular Control
NCT05176379
unknownphase_2
A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)
NCT04734405
Clinical Trials (6)
Showing 6 of 6 trials
NCT04930107Early Phase 1
Vulvovaginal Candidiasis in Canadian Females
NCT07396857Not Applicable
The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting
NCT07342153Phase 4
Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis
NCT05176379Phase 4
Endothelial Derived Hyperpolarization Factor and Vascular Control
NCT04734405Phase 2
A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)
NCT04947592
SD-OCT Guided Treatment of Fungal Chorioretinitis
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6